Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY-NCEBioMedicine

Engineering clinically actionable nanomedicine for cancer immunometabolic ecosystem reprogramming

Related

  1. Pan-cancer analysis identifies nine conserved miRNA regulators of tumor cytolytic activity and clinically actionable immune targets
    N. Bagherlou, S. Aliyari, Z. Salehi +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context‐of‐Use Review
    Yongxin Ye, Martina Colombo, Jennifer Meessen +9
    European journal of clinical investigationPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Clinically Actionable Prevention and Management of Major Complications During Durable Left Ventricular Assist Device Support: A Contemporary Narrative Review
    Wei Yong Sheng, Tian Sheng Tang, You Shi Wu +3
    Cardiology researchPeer-reviewedCC BYFull textCardiovascular medicineEurope PMCPMC
  4. Predicting clinically actionable metagenomic next-generation sequencing in sepsis through dynamic inflammatory trajectories
    Xiaocheng Ding, Peng Bao, Xiaopeng Huang +5
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC
  5. ApoE lipidation state directs immunometabolic reprogramming of human microglia
    Tsion G. Shiferaw, Snigdha Sarkar, Katelyn M. Baker +12
    Alzheimer's & dementia : the journal of the Alzheimer's AssociationPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{gao2026engineering,
  title = {{Engineering clinically actionable nanomedicine for cancer immunometabolic ecosystem reprogramming}},
  author = {Yuhong Gao and Xiulin Dong and Sijia Hua and Lingyun Li and Xiaofeng Zhang and Jianfeng Yang},
  journal = {EBioMedicine},
  year = {2026},
  month = oct,
  doi = {10.1016/j.ebiom.2026.106501},
  url = {https://europepmc.org/article/PMC/PMC13673106},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Engineering clinically actionable nanomedicine for cancer immunometabolic ecosystem reprogramming
AU  - Yuhong Gao
AU  - Xiulin Dong
AU  - Sijia Hua
AU  - Lingyun Li
AU  - Xiaofeng Zhang
AU  - Jianfeng Yang
PY  - 2026
DA  - 2026/10/01
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2026.106501
UR  - https://europepmc.org/article/PMC/PMC13673106
SN  - 2352-3964
ER  -